Diagnostic Significance of Ischemia-Modified Albumin, S100b, and Neuron-Specific Enolase in Acute Ischemic Stroke
EURASIAN JOURNAL OF EMERGENCY MEDICINE, cilt.13, sa.3, ss.112-117, 2014 (ESCI, TRDizin)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 13 Sayı: 3
- Basım Tarihi: 2014
- Doi Numarası: 10.5152/jaem.2014.37980
- Dergi Adı: EURASIAN JOURNAL OF EMERGENCY MEDICINE
- Derginin Tarandığı İndeksler: Emerging Sources Citation Index (ESCI), TR DİZİN (ULAKBİM)
- Sayfa Sayıları: ss.112-117
- Anahtar Kelimeler: Ischemic stroke, ischemic modified albumin, S100 calcium-binding protein beta subunit, neuron-specific enolase, biomarker
- Karadeniz Teknik Üniversitesi Adresli: Evet
Özet
Objective: Use of biochemical markers of cerebral ischemia is a newly favored approach for early diagnosis of ischemic stroke. Our aim was to establish the sensitivity and specificity of ischemia-modified albumin (IMA) in acute ischemic stroke and to compare it with S100b and neuron-specific enolase (NSE). We also intended to investigate the usefulness of a panel composed of these three biomarkers in acute ischemic stroke.